{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:41:29Z","timestamp":1791312089667,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.eururo.2017.03.025","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T02:01:40Z","timestamp":1491616900000},"page":"942-949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report"],"prefix":"10.1016","volume":"72","author":[{"given":"Eric A.","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Chait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Hafron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Kernen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Kestranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Zaslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2017.03.025_bib0105","first-page":"CD004720","article-title":"Screening for prostate cancer, 2013","volume":"2013","author":"Illic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2017.03.025_bib0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"US Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2017.03.025_bib0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.03.025_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrurol.2012.258","article-title":"Aberrant PSA glycosylation--a sweet predictor of prostate cancer","volume":"10","author":"Gilgunn","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2017.03.025_bib0125","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1074\/mcp.M113.030643","article-title":"Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study","volume":"12","author":"Leymarie","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.eururo.2017.03.025_bib0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/glycob\/cwq147","article-title":"Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia","volume":"21","author":"Saldova","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.eururo.2017.03.025_bib0135","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cca.2012.06.007","article-title":"Glycosylation of prostate specific antigen and its potential diagnostic applications","volume":"413","author":"Vermassen","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.eururo.2017.03.025_bib0140","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(01)65405-3","article-title":"Significance of serum free prostate specific antigen in the screening of prostate cancer","volume":"156","author":"Higashihara","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.03.025_bib0145","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0022-5347(05)65075-6","article-title":"Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer","volume":"165","author":"Okihara","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.03.025_bib0150","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1373\/clinchem.2003.026823","article-title":"Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer","volume":"50","author":"Mikolajczyk","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.eururo.2017.03.025_bib0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000020006","article-title":"Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors","volume":"36","author":"Hilz","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.03.025_bib0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1021\/ac5033066","article-title":"Quantitative analysis of prostate specific antigen isoforms using immunoprecipitation and stable isotope labeling mass spectrometry","volume":"87","author":"Chen","year":"2015","journal-title":"Anal Chem."},{"key":"10.1016\/j.eururo.2017.03.025_bib0165","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.7150\/thno.15226","article-title":"Improvement of prostate cancer diagnosis by detecting PSA glycosylation-specific changes","volume":"24","author":"Llop","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.eururo.2017.03.025_bib0170","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.urology.2011.03.071","article-title":"Prostate-specific antigen\/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples","volume":"78","author":"Stovsky","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.03.025_bib0175","unstructured":"National Cancer Institute. EDRN standard operating procedures (SOP). https:\/\/edrn.nci.nih.gov\/resources\/standard-operating-procedures\/standard-operating-procedures."},{"key":"10.1016\/j.eururo.2017.03.025_bib0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.eururo.2017.03.025_bib0185","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.urology.2014.02.035","article-title":"Prostate Cancer Prevention Trial Risk Calculator 2.0 for the prediction of low- vs high-grade prostate cancer","volume":"83","author":"Ankerst","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.03.025_bib0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2015.01.009","article-title":"Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case control study","volume":"68","author":"Stattin","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.03.025_bib0195","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.03.025_bib0200","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.juro.2014.10.121","article-title":"The Prostate Health Index (PHI) selectively identifies clinical-significant prostate cancer","volume":"193","author":"Loeb","year":"2015","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817302361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817302361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T21:56:30Z","timestamp":1535925390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283817302361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0302283817302361"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2017.03.025","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}